Product · market · quality · reviews
We stripped out marketing copy and focused on four things operators actually care about: the product itself, the market it serves, the quality of the detection (accuracy, false alarms, field evidence), and what customers say in real deployments and online reviews.
Competitors analysed
Australian aged-care residential market (IBISWorld)
Global eldercare monitoring TAM
Median blended price — sensing + workflow
Close sense → workflow → documentation
Strategic map
Horizontal axis: dignity / privacy (camera → non-imaging). Vertical axis: workflow depth (raw sensing → closed-loop documentation). Lumana is the only player top-right.
Dots colored by privacy profile. Top-right = dignified + full-workflow. Hover over a dot for the company name.
Full competitor grid
Quality score (0–10) blends online reviews, clinical evidence strength, false-alarm rate, deployment volume, and workflow depth. Sources: AgeTech Labs, AJMC clinical studies, NHS PMC economic evaluations, Medical Device Network, Fierce Biotech, Crunchbase, PRNewswire, Amazon / Capterra reviews.
| Company | Modality | Privacy | Primary value | HQ | Funding | Deployments | Quality | Rating |
|---|
Funding figures are founders'-best-estimate as of April 2026, sourced from Crunchbase, PitchBook and press releases. Customer ratings are paraphrased from public-source quotes and clinical studies; exact scores are directional.
Weighted score of clinical evidence (30%), false-alarm rate (25%), deployment volume (20%), customer reviews (15%), workflow depth (10%).
Funding is plentiful; real deployments are not. Only six competitors have >100 live facilities.
What customers actually say
Paraphrased from public sources: AgeTech Labs product reviews, AJMC / NIH clinical studies, partner press releases, and operator case studies.
"Up to 40% fewer falls and 69% fewer fall-related ER visits in an NIH-sponsored 11-community memory-care study. Residents stayed ~6 months longer at Milestone Retirement."
"For every pound invested, the NHS saves £3.17 including opportunity cost. 96% of surveyed staff said the system helped prevent incidents. Deployed in half of NHS mental-health trusts."
"Most Promising Healthcare Innovation (Flanders 2022). First Belgian pilot: 40 falls detected in 15 rooms in weeks; 4 of 5 falls 'prevented thanks to Nobi's support' per caregivers."
"Camera-free, works in all lighting conditions including dense steam — ideal for bathrooms where 80% of falls occur. Partnered with Austco Tacera, K4Connect, Eevi and Amazon Alexa Together."
"82% average reduction in falls in AL/IL; 75% in SNF. At Friendship Village, deploying in 20% of beds drove a 96% drop in falls-with-injury for the whole unit."
"69% lower fall rate, 39% lower hospitalisation rate, 67% greater length of stay. Staff response times improved 37–40%. But: requires a wearable — uptake is the constraint."
"Stick-figure privacy, ~$200 CAD, ~80% fall-detection accuracy in real-world tests. Strong consumer/B2B solution; lacks clinical-workflow depth for commercial facilities."
"Only FDA 510(k)-cleared UWB-radar device for continuous contactless vitals. 50+ healthcare facility deployments; CPT 99454 Medicare-reimbursable. Vitals-first, not workflow."
"24/7 camera-based fall detection; raw images never viewed by humans. Deployed in Dutch care homes; faces privacy-perception pushback versus pure ambient alternatives."
Asia-Pacific landscape
Three markets, three different purchasing dynamics — but all facing the same structural gap between care-minute mandates and available caregivers.
Design rationale
Lumana isn't the first company to sense in a bedroom or auto-draft a note. It's the first to do both inside a single caregiver workflow — and that's the productisation that matters.
Vayyar, Xandar Kardian, Tellus and Essence proved the market accepts non-imaging radar-class sensors. 80%+ of PERS wearables go unused after a fall. Lumana doubles down on non-imaging.
AltumView's privacy framing — "sensor, not a camera" — is the right vocabulary for staff and families. We adopt the language but go further: no vision at all.
SafelyYou's NIH-validated fall-reduction data is the gold standard. We replicate the methodology for pilots from day one — every pilot generates publishable before/after metrics.
Oxehealth's vision-based model works in NHS MH wards, but JCCPA and the Australian Care Quality Commission push back on recording equipment in bedrooms. We will not ship a camera.
Vayyar and Xandar Kardian sell radar as a component to nurse-call integrators. That strands the workflow problem with someone else. We own it end-to-end.
Every competitor stops at the alert. Lumana carries the alert through triage into an auto-drafted note that staff approve in ten seconds. That's where 13.5 documentation hours per week disappear.
Why Lumana beats the field
Each competitor we analysed excels on one or two of these dimensions. None of them ship all four — which is why most aged-care facilities still run four disconnected systems at once.
Even "privacy-preserving" vision systems lose the dignity narrative in private bedrooms. mmWave + thermal is the only modality an aged-care regulator will defend on stage.
Every pad-based sensor on the market produces ~52% false alarms. Lumana's signals become actionable alerts routed to the nearest caregiver, acknowledged, triaged and tracked.
No one on our map auto-drafts the clinical note. Lumana's auto-drafts are the single largest time-saver and the clearest ROI lever for operators under care-minute audits.
Every other solution is sold à la carte: sensor, integrator, gateway, workflow, records. $85/bed/month as a single bundled subscription turns a procurement epic into a yes/no decision.